Posts under Media

The Endpoints 11: The biotech startups making the biggest bets with the most exciting science in 2023

Posted by amanda punzalan under Media (No Respond)

Biotech Startup Maze Therapeutics Strikes $750 Million Deal With Sanofi

Posted by amanda punzalan under Media (No Respond)

Sanofi bets $750M to enter glycogen-lined Maze deal with lead asset waiting in the middle

Posted by amanda punzalan under Media (No Respond)

Biotech Startup Maze Therapeutics Strikes $750 Million Deal With Sanofi

Posted by amanda punzalan under Media (No Respond)

Sanofi strikes a $150M deal for Maze’s Pompe disease drug

Posted by amanda punzalan under Media (No Respond)

Sanofi’s next chapter in Pompe: $150M for Maze pact as the biotech gears up in CKD

Posted by amanda punzalan under Media (No Respond)

Sanofi stock rises on licensing deal with Maze for potential Pompe disease drug

Posted by amanda punzalan under Media (No Respond)

Early clinical data drove Sanofi’s decision to license Maze’s oral Pompe therapy

Posted by amanda punzalan under Media (No Respond)

Sanofi pumps up its Pompe portfolio with Maze deal

Posted by amanda punzalan under Media (No Respond)

Sanofi Finds Way to Maze Therapeutics to Get Its Next Pompe Disease Drug

Posted by amanda punzalan under Media (No Respond)